Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Healthy Volunteer
Researchers are evaluating the effects of branched chain amino acids BCAAs on recovery from concussion in adolescents and young adults aged 11 to 23 years. This randomized, placebo-controlled, double-blinded clinical trial aims to determine if high-dose BCAAs can promote concussion recovery by comparing them to a placebo. The study builds on previous findings showing a reduction of BCAAs in the brain after injury and potential cognitive improvements with BCAA supplementation. Participants will be randomly assigned to receive either a powder formulation containing the three BCAAs valine, isoleucine, and leucine or a placebo formulation designed to match the BCAA powder in taste, texture, and appearance. The treatment is administered daily to assess its impact on concussion recovery. The study period includes a treatment phase lasting 28 days post-injury. Throughout the study, participants will be monitored closely through clinical and symptom assessments, including concussion symptom levels, visio-vestibular function, pupillary light reflex measurements, sleep quality, and physical activity. The main outcome is the number of participants meeting recovery criteria at 28 days, defined as returning to baseline symptom levels and feeling over 90% back to normal. Safety and adherence will be monitored, with study completion expected by December 2027.